Jun 18, 2026 08:00AM
Jun 18, 2026 08:00AM
May 21, 2026 06:00PM
May 21, 2026 06:00PM
May 7, 2026 04:01PM
Apr 6, 2026 05:55AM
Apr 3, 2026 01:30PM Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
Mar 26, 2026 08:35AM
Mar 25, 2026 04:02PM
Mar 25, 2026 01:05PM
Mar 25, 2026 12:38PM
Mar 25, 2026 11:50AM
Mar 25, 2026 11:50AM
Mar 2, 2026 05:08PM Jefferies Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
Feb 26, 2026 04:01PM
Feb 19, 2026 08:30AM
Feb 5, 2026 02:04PM
Feb 5, 2026 02:00PM
Jan 29, 2026 04:00PM
Jan 29, 2026 04:00PM
Jan 15, 2026 04:22AM Goldman Sachs: 'we view DNLI as attractive given the aforementioned dynamics'
Jan 7, 2026 12:41AM
Jan 6, 2026 08:04AM
Jan 6, 2026 08:00AM
Dec 30, 2025 09:57AM
Dec 30, 2025 08:00AM
Dec 30, 2025 08:00AM
Dec 5, 2025 07:32AM Denali Therapeutics (DNLI) Confident of 2026 Approval for tivi/DNL310 - Stifel
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM
Nov 6, 2025 04:01PM
Nov 6, 2025 04:00PM
Nov 6, 2025 04:00PM
Oct 15, 2025 07:25AM H.C. Wainwright Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
Oct 14, 2025 07:05AM
Oct 13, 2025 04:01PM
Oct 13, 2025 04:01PM
Aug 11, 2025 04:01PM
Jul 7, 2025 10:13AM
Jul 7, 2025 08:03AM
Jul 7, 2025 08:00AM Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
Jun 23, 2025 03:21PM
Jun 5, 2025 12:44PM
May 27, 2025 09:47AM
May 6, 2025 04:01PM
Apr 2, 2025 08:04AM
Apr 2, 2025 08:00AM
Mar 7, 2025 08:12AM Morgan Stanley Starts Denali Therapeutics Inc. (DNLI) at Overweight
Feb 28, 2025 07:11AM

323,571 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All